Nihon Chemical Research KK header image

Nihon Chemical Research KK

4552

Equity

ISIN JP3701000006 / Valor 785030

Tokyo Stock Exchange (2024-09-18)
JPY 653.00%

Nihon Chemical Research KK
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Nihon Chemical Research KK specializes in the development, manufacturing, and sale of chemical products and materials.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (14.08.2024):

Net Sales Increase

Nihon Chemical Research KK reported a 2.1% year-over-year increase in net sales for the year ended March 31, 2023. This growth was primarily driven by revisions to selling prices, despite a challenging economic environment marked by rising raw material and fuel prices, and the weakening of the yen.

Operating Profit Decline

Despite the increase in net sales, Nihon Chemical Research KK experienced a significant 67.0% decrease in operating profit for the same period. The decline was attributed to reduced capacity utilization due to rapid production adjustments by major customers.

Segment Performance

In the Inorganic Chemicals segment, net sales increased by 26.2% year-over-year, driven by strong performance in chromium compounds and inorganic phosphorus compounds. However, the Specialty Chemicals segment saw an 8.3% decline in net sales, impacted by weak demand in certain product categories.

Capital Investments

Nihon Chemical Research KK made substantial capital investments in its Specialty Chemicals division. Notable projects include the construction of facilities for dielectric materials for MLCC at the Tokuyama Factory, expected to be completed in FY 2024, and high-purity red phosphorus for semiconductors at the Fukushima No. 2 Factory, completed in May 2022.

Future Outlook

For the year ending March 31, 2024, Nihon Chemical Research KK forecasts a 5.1% increase in net sales and a 23.8% rise in operating profit. The company anticipates a slow recovery in demand for LCDs, semiconductors, and communication products, while continuing to invest in growth areas such as electronic ceramic materials for automobiles.

Summarized from source with an LLMView Source

Key figures

-54.8%1Y
-78.2%3Y
-67.1%5Y

Performance

44.2%1Y
42.1%3Y
41.5%5Y

Volatility

Market cap

664 M

Market cap (USD)

Daily traded volume (Shares)

284,800

Daily traded volume (Shares)

1 day high/low

666 / 649

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Galapagos NV
Galapagos NV Galapagos NV Valor: 2130343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.30%EUR 27.34
Terveystalo Oyj
Terveystalo Oyj Terveystalo Oyj Valor: 37893402
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.83%EUR 9.59
Merck KGaA
Merck KGaA Merck KGaA Valor: 412799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.39%EUR 166.00
Fresenius Medical Care AG
Fresenius Medical Care AG Fresenius Medical Care AG Valor: 520878
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.27%EUR 37.42
Medios AG
Medios AG Medios AG Valor: 19069483
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.72%EUR 16.58
Limes Schlosskliniken AG
Limes Schlosskliniken AG Limes Schlosskliniken AG Valor: 38625581
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.06%EUR 372.00
APONTIS PHARMA AG
APONTIS PHARMA AG APONTIS PHARMA AG Valor: 111377632
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.44%EUR 6.86
MPH Health Care AG
MPH Health Care AG MPH Health Care AG Valor: 57233620
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.56%EUR 26.00
2invest AG
2invest AG 2invest AG Valor: 110098281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.93%EUR 10.60
The Platform Group AG
The Platform Group AG The Platform Group AG Valor: 57796644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.24%EUR 8.38